{{Rsnum
|rsid=4731702
|Chromosome=7
|position=130748625
|Orientation=plus
|GMAF=0.3737
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 24.5 | 56.4 | 19.1
| HCB | 45.1 | 47.4 | 7.5
| JPT | 41.8 | 50.0 | 8.2
| YRI | 55.6 | 41.3 | 3.2
| ASW | 37.0 | 55.6 | 7.4
| CHB | 45.1 | 47.4 | 7.5
| CHD | 45.4 | 44.4 | 10.2
| GIH | 35.0 | 45.0 | 20.0
| LWK | 48.6 | 45.8 | 5.6
| MEX | 32.8 | 48.3 | 19.0
| MKK | 60.0 | 35.5 | 4.5
| TSI | 29.6 | 55.1 | 15.3
| HapMapRevision=28
}}http://www.medhours.com/master-gene-controls-fat-metabolism/ The enrichment of rs4731702 trans associations for low P values suggests that KLF14 is a master regulator of gene expression in adipose tissue

{{PMID Auto GWAS
|PMID=20686565
|Trait=None
|Title=Biological, clinical and population relevance of 95 loci for blood lipids.
|RiskAllele=T
|Pval=1E-15
|OR=0.5900
|ORtxt=None
|OA=1
}}

{{PMID|19936222|OA=1
}} Forty-three loci associated with plasma lipoprotein size, concentration, and cholesterol content in genome-wide analysis.

{{PMID Auto
|PMID=24195066
|Title=Association of the KLF14 rs4731702 SNP and Serum Lipid Levels in the Guangxi Mulao and Han Populations
|OA=1
}}

{{PMID Auto
|PMID=22702842
|Title=Genome-wide association study validation identifies novel loci for atherosclerotic cardiovascular disease.
}}

{{PMID Auto
|PMID=23630301
|Title=Strong parent-of-origin effects in the association of KCNQ1 variants with type 2 diabetes in American Indians.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}